Free Trial

JELD-WEN (JELD) to Release Earnings on Monday

JELD-WEN logo with Construction background
Image from MarketBeat Media, LLC.

Key Points

  • JELD-WEN will report Q1 2026 results after the market close on Monday, May 4, with an investor call on Tuesday, May 5 at 8:00 AM ET; analysts forecast EPS of ($0.2921) and revenue of $721.8 million.
  • In the prior quarter the company missed earnings—EPS ($0.42) vs. ($0.23) expected—showing a negative net margin (~18.96%) and negative ROE (~29.63%) even though revenue beat estimates at $801.96 million.
  • Analyst sentiment is cautious (consensus "Reduce"/Hold with a $3.35 target) while institutional investors own about 95% of the stock, and several large funds have recently increased their positions.
  • Five stocks we like better than JELD-WEN.

JELD-WEN (NYSE:JELD - Get Free Report) will likely be posting its Q1 2026 results after the market closes on Monday, May 4th. Analysts expect JELD-WEN to post earnings of ($0.2921) per share and revenue of $721.7840 million for the quarter. Individuals may visit the the company's upcoming Q1 2026 earning results page for the latest details on the call scheduled for Tuesday, May 5, 2026 at 8:00 AM ET.

JELD-WEN (NYSE:JELD - Get Free Report) last issued its earnings results on Tuesday, February 17th. The company reported ($0.42) EPS for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.19). JELD-WEN had a negative net margin of 18.96% and a negative return on equity of 29.63%. The business had revenue of $801.96 million during the quarter, compared to analysts' expectations of $747.20 million.

JELD-WEN Stock Performance

Shares of JELD stock opened at $1.46 on Monday. The company's fifty day simple moving average is $1.50 and its 200-day simple moving average is $2.46. JELD-WEN has a 52 week low of $0.93 and a 52 week high of $6.98. The company has a current ratio of 1.76, a quick ratio of 0.99 and a debt-to-equity ratio of 12.47. The company has a market cap of $125.58 million, a PE ratio of -0.20 and a beta of 1.91.

Institutional Investors Weigh In On JELD-WEN

Several hedge funds and other institutional investors have recently added to or reduced their stakes in JELD. One Fin Capital Management LP purchased a new stake in JELD-WEN during the 4th quarter worth $4,920,000. Arrowstreet Capital Limited Partnership purchased a new stake in JELD-WEN during the 3rd quarter worth $9,730,000. Millennium Management LLC increased its stake in JELD-WEN by 76.2% during the 3rd quarter. Millennium Management LLC now owns 2,673,994 shares of the company's stock worth $13,129,000 after buying an additional 1,156,751 shares during the period. Federated Hermes Inc. increased its stake in JELD-WEN by 45.6% during the 4th quarter. Federated Hermes Inc. now owns 3,338,835 shares of the company's stock worth $8,214,000 after buying an additional 1,045,273 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in JELD-WEN by 23.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,429,498 shares of the company's stock worth $10,897,000 after buying an additional 840,034 shares during the period. Hedge funds and other institutional investors own 95.04% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. The Goldman Sachs Group cut their target price on shares of JELD-WEN from $3.75 to $3.25 and set a "neutral" rating on the stock in a research note on Tuesday, January 13th. Weiss Ratings reissued a "sell (e+)" rating on shares of JELD-WEN in a research note on Monday, December 29th. Finally, Zacks Research raised shares of JELD-WEN from a "strong sell" rating to a "hold" rating in a research note on Tuesday, January 6th. Six investment analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of "Reduce" and a consensus price target of $3.35.

View Our Latest Research Report on JELD-WEN

About JELD-WEN

(Get Free Report)

JELD-WEN is a global manufacturer of windows and doors and related building products, serving both residential and commercial markets. The company's portfolio includes wood, vinyl and aluminum windows; interior wood doors; and exterior doors crafted from steel, fiberglass and composite materials. JELD-WEN's products are designed for new construction and remodeling applications, with an emphasis on quality, durability and energy efficiency.

Founded in 1960 in Klamath Falls, Oregon, JELD-WEN has grown through a combination of organic expansion and strategic acquisitions to establish a manufacturing footprint in North America, Europe and Australasia.

Featured Articles

Earnings History for JELD-WEN (NYSE:JELD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in JELD-WEN Right Now?

Before you consider JELD-WEN, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JELD-WEN wasn't on the list.

While JELD-WEN currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines